Breast cancer surveillance for BRCA1/2 mutation carriers – is “early detection” early enough?

BACKGROUND: Annual MRI screening is associated with a significant reduction in advanced-stage breast cancer diagnosis in BRCA1/2 mutation carriers. The impact that early detection has on subsequent oncological treatment is less frequently reported. In this study we compared disease stage and therape...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast
Main Authors: Bernstein-Molho, Rinat, Kaufman, Bella, Ben David, Merav A., Sklair-Levy, Miri, Feldman, Dana Madoursky, Zippel, Dov, Laitman, Yael, Friedman, Eitan
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7375664/
https://ncbi.nlm.nih.gov/pubmed/31760168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2019.10.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados